Latest Financial Results News

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Web Travel Group Limited has reported a robust first half of FY26 with a 22% increase in Total Transaction Value and EBITDA growth surpassing expectations, setting a confident tone for the year ahead.

WEB Travel Group has reported a stellar first half of FY26, posting a 22% rise in Total Transaction Value to $3.2 billion alongside strong EBITDA growth, signaling robust momentum ahead of full-year results.

Web Travel Group Limited reports robust half-year results for FY26, with its B2B travel division WebBeds fueling a 20% revenue increase despite rising costs and finance pressures.

Pacific Edge reports a $19.1 million net loss for the first half of FY26 amid Medicare coverage loss but positions itself for a Medicare-led recovery with strong clinical evidence and a key advisory committee meeting set for February 2026.

Euroz Hartleys Group Limited reported a robust FY2025 with an 87.7% jump in net profit and a strong start to FY2026, driven by increased brokerage and capital markets activity.

Elanor Investors Group has extended deadlines for a $125 million investment from Rockworth Capital Partners and the acquisition of Firmus, with a key shareholder meeting now scheduled for late January 2026.

Chrysos Corporation reports nearly one million monthly PhotonAssay samples and reiterates strong FY26 revenue guidance, while unveiling next-gen assay technologies and global expansion plans.

Chrysos Corporation reported record FY25 financial results, driven by strong global demand for its innovative PhotonAssay™ technology. The company expanded its footprint, enhanced sustainability credentials, and strengthened governance, positioning itself for continued growth.

SPC Global Holdings delivered a transformational FY25 with robust financial results and strategic international growth, setting the stage for a confident 25% EBITDA increase in FY26.

Pro Medicus Ltd has delivered a record-breaking FY2025 with revenue soaring nearly 32% and net profit up 39%, driven by landmark contracts and a robust growth pipeline.

Metro Performance Glass Limited has returned to profitability in the first half of 2025, posting a NZD 4.5 million profit before tax and significantly reducing its debt through a NZD 23.9 million equity raise.